Cargando…
Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells
BACKGROUND: Glioma is the most common highly aggressive, primary adult brain tumour. Clinical data show that therapeutic approaches cannot reach the expectations in patients, thus gliomas are mainly incurable diseases. Tumour cells can adapt rapidly to alterations during therapeutic treatments relat...
Autores principales: | Petővári, Gábor, Hujber, Zoltán, Krencz, Ildikó, Dankó, Titanilla, Nagy, Noémi, Tóth, Fanni, Raffay, Regina, Mészáros, Katalin, Rajnai, Hajnalka, Vetlényi, Enikő, Takács-Vellai, Krisztina, Jeney, András, Sebestyén, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300020/ https://www.ncbi.nlm.nih.gov/pubmed/30574020 http://dx.doi.org/10.1186/s12935-018-0710-0 |
Ejemplares similares
-
Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells
por: Petővári, Gábor, et al.
Publicado: (2019) -
In Situ Metabolic Characterisation of Breast Cancer and Its Potential Impact on Therapy
por: Petővári, Gábor, et al.
Publicado: (2020) -
GABA, glutamine, glutamate oxidation and succinic semialdehyde dehydrogenase expression in human gliomas
por: Hujber, Zoltán, et al.
Publicado: (2018) -
Metabolic Adaptation as Potential Target in Papillary Renal Cell Carcinomas Based on Their In Situ Metabolic Characteristics
por: Krencz, Ildikó, et al.
Publicado: (2022) -
Characterisation of 3D Bioprinted Human Breast Cancer Model for In Vitro Drug and Metabolic Targeting
por: Dankó, Titanilla, et al.
Publicado: (2022)